top of page


EVEXIA Bio Fund regularly publishes our research, diligence, and investment theses as articles here on the EVEXIA website and on the crowd-sourced investing content platform Seeking Alpha in order to make our research and diligence more accessible to current and future members.

Autolus: Undervalued Allogeneic CAR-T Therapy Company

Quanterix: Disruptive Potential Dependent On Yet-Undiscovered Applications

2018 Is An Ideal Entry Point For Aurinia Pharmaceuticals

2018 Q4 Catalysts and Strong Technology Platform Drive Merus’ Value

bottom of page